REFERENCES
1. Basa ML, Cha DS, Mitchell DP, Chan DL. Metabolic bariatric surgery, alcohol misuse and liver cirrhosis: a narrative review. Metab Target Organ Damage 2024;4:29.
2. Chung Y, Paik B, Jeon D, Kim YJ. Obesity, kidney and metabolic bariatric surgery: a surgeon’s narrative review. Metab Target Organ Damage 2024;4:38.
3. Em ST, Parikh MS, Orandi BJ, Ren-fielding CJ. Bariatric surgery in patients with obesity and end-stage heart failure with left ventricular assist devices: a brief guide. Metab Target Organ Damage 2024;4:39.
4. Péres A, Bernhardt J, Tibolla V. Evaluation of weight loss and quality of life in long-term post-bariatric surgery. Metab Target Organ Damage 2024;4:26.
5. Huele AV, Buchwald JN, Mcglennon TW, Dillemans B. Primary banded RYGB, banded long-limb RYGB, and revisional B-RYGB: weight loss and complications at one-year follow-up. Metab Target Organ Damage 2024;4:12.
6. Baldwin D, Ali AM, Altieri MS, Demaria EJ. Marginal ulceration after Roux-en-Y gastric bypass - literature review and management algorithm. Metab Target Organ Damage 2024;4:6.
7. Harrington S, Kang S, Telesca L, Cohen RV, Roux CWL. Long-term complications of significant weight loss: lessons learned from bariatric surgery. Metab Target Organ Damage 2023;4:11.
8. Pantelis AG. Standardizing outcomes in metabolic bariatric surgery - more than meets the eye, less than counts the scale. Metab Target Organ Damage 2023;4:8.
